DHA Fish Oils Same As Placebo For Patients With Alzheimer’s Disease
Researchers report that those with mild/moderate Alzhimer’s Disease symptoms who received omega-3 DHA fatty acid (docosahexaenoic acid) over an 18-month period experienced the same rates of cognitive and functional decline as those on a placebo. Their study has been published in today’s issue of JAMA (Journal of the American Medical Association) which focuses on aging this week…
November 2, 2010 · by · in Nutritional News · Tags: 18-month-period, alzheimer's / dementia, alzhimer, been-published, fatty-acid, focuses-on-aging, nutritional counseling, oncalldiets, the-same, week